Related Experiment Videos
A formulary for lizards, snakes, and crocodilians
1Mesa Veterinary Hospital, Ltd., Mesa, Arizona, USA.
Summary
This study provides a drug dosage formulary for reptiles, including lizards, snakes, and crocodilians. It compiles essential antimicrobial, parasiticide, anesthetic, analgesic, and miscellaneous drug information from existing literature.
Area of Science:
- Veterinary Medicine
- Herpetology
- Pharmacology
Background:
- Accurate drug dosages are critical for effective treatment in reptiles.
- Existing literature on reptile pharmacotherapy is fragmented and requires synthesis.
- Lizards, snakes, and crocodilians represent diverse reptilian groups with unique physiological considerations.
Purpose of the Study:
- To create a comprehensive drug formulary for veterinary use in lizards, snakes, and crocodilians.
- To consolidate and present drug dosage information based on a thorough literature review.
- To serve as a practical reference for veterinarians and researchers treating these reptilian species.
Main Methods:
- Conducted an extensive survey of existing scientific literature on reptile drug dosages.
- Compiled and organized drug information into four distinct categories: antimicrobials, parasiticides, anesthetics/analgesics, and miscellaneous drugs.
- Ensured data accuracy and relevance for application in clinical veterinary practice.
Main Results:
- Developed a structured formulary detailing drug dosages for various reptile species.
- The formulary includes specific recommendations for antimicrobial, parasiticide, anesthetic, analgesic, and other drug classes.
- An extensive bibliography supports the compiled information, facilitating further research.
Conclusions:
- The presented formulary provides a valuable, consolidated resource for reptile pharmacotherapy.
- This compilation aids in standardizing drug use and improving treatment outcomes for lizards, snakes, and crocodilians.
- The extensive bibliography supports ongoing research and clinical application in reptile medicine.